Flexpro extra (Acetaminophen,Methocarbamol)

Quick links

Choose a section

Quick links to important sections

Advertisements

Flexpro extra (Acetaminophen,Methocarbamol)

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Flexpro extra (Acetaminophen,Methocarbamol)

Property Description
Active Ingredients Acetaminophen, Methocarbamol
Form Oral Solid Dosage (Tablets, Caplets)
Pharmacological Class Non-opioid Analgesic and Centrally Acting Skeletal Muscle Relaxant
Common Use Symptomatic relief of acute, painful musculoskeletal conditions
Origin Synthetic Compounds

Flexpro extra: A Combination Drug and Pharmacological Class

Flexpro extra (Acetaminophen, Methocarbamol) is a prescription combination product classified concurrently as a non-opioid analgesic and a centrally acting skeletal muscle relaxant. This synthetic medicine is engineered to provide comprehensive symptomatic relief for discomfort associated with acute musculoskeletal conditions. The inclusion of two distinct active ingredients allows it to belong to two separate pharmacological classes, a strategy clinically recognized for addressing the dual symptoms of pain and spasm simultaneously.

The active component Methocarbamol is specifically identified as a skeletal muscle relaxant and has been documented for its role in managing acute musculoskeletal pain. This means the drug helps ease muscle tightness and spasms by acting on the central nervous system. This dual-classification profile differentiates the product from single-entity preparations, which target either pain (like Acetaminophen alone) or muscle tension exclusively.


What are the Active Ingredients in Flexpro extra and What is its Purpose?

The active ingredients in Flexpro extra are Acetaminophen (or Paracetamol) and Methocarbamol, which together define its general therapeutic purpose. Acetaminophen functions as an analgesic and antipyretic agent, primarily utilized for treating pain and fever. This confirms that a general benefit of the medicine is its ability to help lower fever and reduce pain. Methocarbamol, a synthetic derivative, works centrally to promote muscle relaxation by calming overactive nerves.

The general therapeutic purpose is its use as an adjunct therapy for the acute phase of painful conditions involving muscle spasms and stiffness, such as the discomfort following a strain or minor injury. The integrated action of these two synthetic compounds allows the product to address both the pain sensation and the involuntary muscle tightness that underlies the discomfort, thereby reducing the overall burden of the musculoskeletal issue. Flexpro extra is supplied as an oral solid dosage form, intended to be taken via the oral route of administration.

Advertisements

What side effects are possible with Flexpro extra (Acetaminophen,Methocarbamol)?

Possible side effects and safety information

The safety profile of this combination product, containing Acetaminophen and Methocarbamol, is officially classified and documented by government regulatory agencies based on the adverse reactions associated with both components.

Adverse Reactions and Frequencies

Adverse reactions are grouped according to the system-organ class affected. Effects related to the Nervous System are generally the most common, driven by the Methocarbamol component.

Classification Examples of Officially Documented Effects
Common Drowsiness (somnolence), dizziness, nausea, lightheadedness, vomiting, and headache.
Uncommon Confusion, pruritus (itching), skin rash, and urticaria (hives).

Serious Adverse Reactions

Official labeling documents certain serious adverse reactions, which are typically rare but clinically significant:

  • Severe Hepatotoxicity (Liver Damage): This risk is primarily associated with the Acetaminophen component and is dose-dependent, mandating strict adherence to the maximum daily dose constraint.
  • Severe Hypersensitivity: Including anaphylaxis and angioedema, which are officially documented as rare but serious immune system disorders.
  • Blood Dyscrasias: Rare, severe hematological effects such as agranulocytosis or thrombocytopenia.

Population-Specific Safety Considerations

The product is restricted or contraindicated in individuals with severe hepatic impairment due to the risk of Acetaminophen-induced liver damage. Furthermore, older adults may experience a heightened risk of central nervous system effects, such as dizziness and sedation, necessitating cautious use as per regulatory notes.

Safety Patterns and Constraints

Official regulatory documents note that CNS adverse effects are often more prominent at the initiation of therapy. A high-level safety constraint is the mandatory limitation of the maximum daily dose to mitigate the severe risk of hepatotoxicity. Additionally, Methocarbamol is documented to cause benign urine discoloration (brown, black, or green) and may interfere with certain laboratory tests.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that overdose requires immediate medical attention due to the distinct, severe risks associated with both active components. Overdose is classified as potentially life-threatening and associated with acute liver failure and CNS depression.

Documented Overdose Manifestations and Severe Outcomes

Component Documented Manifestations Severe Outcomes
Acetaminophen Nausea, vomiting, abdominal pain, sweating; symptoms may be delayed or initially absent. Severe hepatic injury, acute liver failure, death.
Methocarbamol Severe drowsiness, blurred vision, hypotension, confusion. Seizures, coma, death (especially when combined with CNS depressants).

Required Emergency Actions and Management

Immediate medical attention is required for a suspected overdose, even if no symptoms are present. Regulatory documents mandate contacting emergency services or a certified Poison Help Center right away.

Treatment management for the Acetaminophen component includes the required administration of the specific antidote, N-acetylcysteine. For the Methocarbamol component, management is restricted to symptomatic and supportive treatment, including the maintenance of an adequate airway and monitoring of vital signs. Official procedures require extensive laboratory monitoring, including measurement of plasma acetaminophen concentration and assessment of hepatic and renal function.

Advertisements

Therapeutic Uses of Flexpro extra (Acetaminophen,Methocarbamol)

What Flexpro extra Treats: Main Uses

Flexpro extra is indicated for use as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The medication combines two active components to address both muscle spasm and associated pain.

Therapeutic Benefits

  • Relief of Muscle Spasm: The component Methocarbamol is a centrally acting agent that works to relieve involuntary skeletal muscle spasms and muscle tension. It is used for the symptomatic treatment of muscle spasms that are painful and associated with acute disorders affecting the muscles and bones, such as back pain.
  • Pain Management: The component Acetaminophen (also known as Paracetamol) is an analgesic that helps to alleviate the pain experienced in these acute musculoskeletal conditions.

This combination is intended for the short-term, symptomatic management of painful muscle spasms.


Quick Facts

  • Relieves discomfort linked to acute, painful musculoskeletal conditions.
  • Addresses involuntary skeletal muscle spasms.
  • Aids in the symptomatic management of associated pain.

Regulatory References

  1. NIH MedlinePlus guidance
Advertisements

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Flexpro extra

Official regulatory documents define specific populations who are eligible, restricted, or prohibited from using Flexpro extra (Acetaminophen, Methocarbamol).

Contraindications and Restrictions

Classification Population Restriction
Absolute Contraindication Patients with known hypersensitivity to Methocarbamol, Acetaminophen, or any inactive component. Use is strictly prohibited for those with severe hepatic impairment or severe active liver disease.
Age Restriction Safety and effectiveness have not been established in children younger than 16 years of age, making them ineligible for standard use.
Physiological Status Generally not recommended during pregnancy; use is conditional on a clear benefit/risk assessment. Caution is advised during lactation as Methocarbamol's presence in human milk is unknown.
Conditional Use Patients with impaired renal function, non-severe hepatic impairment, a history of seizures, or Myasthenia Gravis require heightened caution and specific medical guidance. Geriatric patients may be more sensitive to the central nervous system effects.

Eligible Population

Flexpro extra is indicated for use by adults and adolescents aged 16 years and older under standard labeled conditions, provided no contraindications are present.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Flexpro extra contains both acetaminophen and methocarbamol, and its interaction profile is defined by the known risks associated with each component.

Central Nervous System Depressants

Methocarbamol, a centrally acting muscle relaxant, can cause additive effects when taken with other central nervous system (CNS) depressants. This can lead to increased drowsiness, sedation, or respiratory depression. Specific categories of interacting products include:

  • Alcohol
  • Opioid pain and cough relievers (e.g., hydrocodone, codeine)
  • Barbiturates
  • General anesthetics
  • Psychotropic drugs

Concomitant use with opioid agonists is considered a major interaction and should generally be avoided due to the significant risk of serious adverse reactions. If concurrent use is deemed necessary, initial dosages of the opioid should be reduced and carefully monitored.

Acetaminophen-Related Interactions

The acetaminophen component requires specific precautions, primarily to prevent severe liver damage (hepatotoxicity):

  • Do not use this product with any other medicine (prescription or over-the-counter) that contains acetaminophen. Taking multiple products with acetaminophen can exceed the maximum safe daily dose.
  • Alcohol: Severe liver damage may occur if acetaminophen is used while consuming three or more alcoholic drinks per day. It is generally advised to avoid or limit alcohol intake while taking acetaminophen-containing products.

Other Interacting Agents

Methocarbamol may also inhibit the effect of anticholinesterase agents, such as pyridostigmine bromide. Therefore, caution is advised when using this medicine in patients with myasthenia gravis who are receiving these agents.

Advertisements

Mechanism of Action

The mechanism of action for this combination involves two distinct pharmacodynamic profiles: Acetaminophen and Methocarbamol.

Acetaminophen primarily acts within the central nervous system (CNS). It functions as an indirect inhibitor of the cyclooxygenase (COX) pathway, specifically reducing the activity of prostaglandin-endoperoxide synthase, which decreases prostaglandin synthesis in the CNS. Additionally, a metabolite, AM404, may modulate the cannabinoid system by inhibiting the uptake or degradation of anandamide, thereby activating transient receptor potential vanilloid subtype-1 (TRPV1) receptors in the dorsal horn of the spinal cord. This intracellular signaling leads to an increase in the descending serotonergic inhibitory pathways.

Methocarbamol is a centrally acting skeletal muscle relaxant whose precise molecular mechanism is not fully elucidated. Its effects are mediated through general CNS depression. The substance is thought to block spinal polysynaptic reflexes and decrease nerve transmission in both spinal and supraspinal polysynaptic pathways. This modulation of interneuronal activity results in systemic depression of muscle tone, without a direct effect on the skeletal muscle fiber or the motor end plate.

Advertisements

Dosage and Administration Information

The combination medicine of Acetaminophen and Methocarbamol is officially administered via the oral route using the tablet or caplet dosage form. The use of this drug is strictly intended for short-term administration, serving as an adjunct to rest and physical therapy for the management of acute musculoskeletal conditions.

The standardized adult dosing regimen typically involves taking two caplets or tablets per administration. This dose commonly delivers Methocarbamol 800 mg and Acetaminophen 1000 mg. This schedule is generally administered on a divided dose basis, most often established as every 6 hours as needed to maintain the labeled dosing intervals.

A fundamental procedural instruction involves the mandatory maximum daily limit on intake. General guidelines specify that total consumption must not exceed 4,000 mg of Acetaminophen in a 24-hour period from all sources. For a formulation containing 500 mg of Acetaminophen per unit, this limits the total daily intake of the combination product to eight tablets or caplets.

Regarding the practical administration context, the tablets are intended to be swallowed whole and may be taken either with or without food. Standard instructions generally restrict the use of this medication to adults and pediatric patients 12 years of age and over. High-level instructions note that older adults and individuals with hepatic impairment may require special consideration due to altered drug clearance, though specific dosage mandates may vary.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Flexpro extra (Acetaminophen, Methocarbamol)

Evidence for Use in Acute, Painful Musculoskeletal Conditions

Research has examined Flexpro extra for its approved indication for the study of symptoms in acute conditions that involve both pain and involuntary muscle spasm. This research primarily relies on Randomized Controlled Trials (RCTs) focusing on the muscle relaxant component, Methocarbamol, used either alone or in similar combination structures, as well as Systematic Reviews that synthesize findings across multiple studies. These studies were conducted during periods of increased symptom activity in adult populations experiencing acute physical discomfort.

The main focus of these trials was to monitor patient-reported outcomes describing perceived discomfort. Outcomes related to physical discomfort and daily functioning or activity level were evaluated using standardized rating tools. Findings from these short-term studies describe patterns observed in the research, reporting patterns of change in measured physical discomfort and muscle tension during the study period. An independent European regulatory review also contributed to understanding symptom patterns after reviewing the combination product's regulatory documentation based on the known actions of its components in acute settings. However, data show patterns related to short-term changes only, as the observation intervals were typically limited to a few days or one week.


Evidence Specific to Acute Low Back Pain with Muscle Spasm

Research exploring how the Methocarbamol component was studied for the involuntary muscle contraction element of back pain centers on this specific indication—a condition characterized by fluctuating or episodic manifestations. Controlled clinical studies and RCTs have explored how the treatment was studied in adults experiencing acute LBP that restricts mobility. This research specifically examined outcomes reflecting daily functioning and outcomes capturing phases of heightened symptom activity.

Research during these episodes where symptoms become more noticeable has explored outcomes such as the time interval measured for changes in pain reporting and measures of mobility. In some studies, findings suggest that patients reported changes in pain intensity and associated mobility restrictions compared to control groups. The findings from these studies were used to support its classification as an adjunctive treatment and contribute to the broader understanding of short-term changes in conditions associated with acute or disruptive episodes.


Long-Term Studies and Follow-Up Duration

Most clinical research conducted for Flexpro extra and its active components was relevant in trials assessing short-term or episodic symptom patterns. The follow-up durations were limited, often spanning only seven to eight days when studying acute musculoskeletal conditions. This short duration reflects the focus of research on temporary, acute discomfort.

While some studies monitored outcomes for up to three months, this intermediate-term follow-up typically focused on functional status rather than continuous medication use. Therefore, there is limited information for long-term outcomes regarding the durability of any observed changes or the persistence of symptom patterns beyond the typical acute treatment period. The lack of extended data means that long-term effects are not fully established and cannot be characterized based on current evidence.


What is Still Uncertain in the Research Landscape

The research contributes to the broader evidence landscape, yet key gaps and limitations persist. Evidence is limited when looking for recent, high-quality Randomized Controlled Trials that compare the precise fixed-dose combination of Acetaminophen and Methocarbamol directly against a placebo. Furthermore, the overall certainty remains low for some findings regarding the general class of non-benzodiazepine muscle relaxants in systematic reviews due to varying study methodologies.

Key Studies & References

  1. Methocarbamol: Drug Label Information (Summary of Clinical Studies and Indications)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Flexpro extra (Acetaminophen,Methocarbamol) (FAQ)


Q: How quickly does Flexpro extra typically start working for muscle pain?

Official product information indicates that the methocarbamol component of Flexpro extra is absorbed relatively quickly. Concentrations of the substance can often be measured in the blood within 30 minutes of administration. However, the time interval to observed changes in symptoms is variable.


Q: How long can the effects of Flexpro extra be expected to last?

Official pharmacological data describes the half-life of methocarbamol as generally being between one and two hours in adults. The half-life is the time required for the body to reduce the amount of substance by half. This information helps describe the timeframe in which the body processes the medication.


Q: Is it normal to feel dizzy or lightheaded after taking Flexpro extra?

Yes, according to official documents, both dizziness and lightheadedness are classified as common adverse reactions to this medication. This means that these effects have been frequently reported in clinical trials and are not unusual when taking the drug.


Q: Is a metallic taste in the mouth a known side effect of Flexpro extra?

Official documentation for the methocarbamol component lists changes in taste, including a metallic taste, as a reported adverse effect.


Q: Can Flexpro extra cause changes in the color of urine?

Yes, official drug labels document that the methocarbamol component may cause a change in the color of urine, which can appear brown, black, or green. This is generally considered an expected effect related to how the medicine is processed by the body.


Q: Does Flexpro extra interact with over-the-counter pain relievers like Ibuprofen or Naproxen?

Official labels indicate caution is warranted when combining the product with other medications that cause Central Nervous System (CNS) depression or have unknown interaction profiles. Reviewing all drug labels carefully is generally noted.


Q: What is the research evidence regarding Flexpro extra's effectiveness for acute lower back pain?

Research examining the approved use focuses on the short-term relief of symptoms in acute conditions that involve both pain and muscle spasm. This research indicates that it is intended for use alongside other therapies, such as rest and physical therapy, for conditions like acute lower back pain.


Q: Are there any official warnings about taking Flexpro extra with specific types of foods or drinks?

Official instructions state that the tablets may be taken either with or without food. The primary warning regarding drinks concerns alcohol consumption, due to the potential for severe liver damage when combined with the acetaminophen component. No other specific food warnings are generally documented.


Q: Can Flexpro extra be used to treat muscle spasms related to physical therapy or injury recovery?

The official indication for this drug is its use as an adjunct therapy, meaning it is meant to be used in addition to rest and physical therapy. It is indicated for the management of acute, painful conditions involving muscle spasms, which may occur during injury recovery.


Q: What is the difference between Flexpro extra and taking separate pills of acetaminophen and methocarbamol?

Official classification defines Flexpro extra as a fixed-dose combination product. This means the specific amounts of acetaminophen and methocarbamol are combined into a single tablet. The product is regulated and studied as this specific combined entity designed for simultaneous administration.


Q: Is Flexpro extra an NSAID?

No, Flexpro extra is not classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). It is officially classified as a non-opioid analgesic (pain reliever) and a centrally acting skeletal muscle relaxant, reflecting its dual active ingredients.


Q: Is Flexpro extra considered an opioid or controlled substance?

No, Flexpro extra is officially classified as a non-opioid analgesic. Furthermore, the active ingredient methocarbamol is not currently listed as a controlled substance under the U.S. Controlled Substances Act.


Q: Is there a risk of developing a physical dependence on Flexpro extra?

The official label for methocarbamol-containing products includes warnings about the potential for abuse and dependence. This risk is particularly noted when the drug is used improperly or taken for periods longer than intended.


Q: Is it safe to take Flexpro extra with antidepressant medications?

Official labels include warnings regarding concurrent use with other Central Nervous System (CNS) depressants, a category that includes many antidepressant and psychotropic drugs. Combining these medications may increase the risk of side effects like additive sedation and drowsiness.


Q: Does official information state whether Flexpro extra passes into breast milk?

Official documents state that while the acetaminophen component is known to pass into breast milk in small amounts, the presence of methocarbamol in human milk is unknown. The use of the drug during lactation requires careful consideration.


Q: Are there official studies comparing the effectiveness of Flexpro extra to other muscle relaxants?

Regulatory summaries of clinical research typically focus on comparing the drug's effects to a placebo (an inactive treatment) or monitoring changes from a baseline level of discomfort. The official documents do not typically contain summaries of direct, head-to-head trials comparing Flexpro extra against other specific muscle relaxants.


Q: What is the recommended maximum amount of acetaminophen that should be taken daily while using Flexpro extra?

According to official regulatory guidance, the mandatory maximum daily intake limit for acetaminophen from all sources is 4,000 mg in a 24-hour period for standard adult populations. It is important to account for acetaminophen content from all products being used.


Q: Can taking Flexpro extra cause stomach upset or nausea?

Yes, according to official drug labels, nausea and vomiting are listed as commonly reported adverse reactions. These effects are frequently observed side effects when taking the medication.


Q: Does the use of Flexpro extra affect any common laboratory test results?

Yes, official drug labeling notes that the methocarbamol component is documented to cause interference with certain laboratory screening tests. Specifically, it can interfere with tests for 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).


Q: Is it possible for Flexpro extra to cause insomnia or trouble sleeping?

While the most common side effect is drowsiness, official labels have also listed other effects such as confusion and agitation. These types of central nervous system effects may be noted in some individuals and could indirectly affect normal sleep patterns.


Q: Does Flexpro extra interact with natural or herbal supplements?

The official drug label provides a general warning about potential interactions with other medications that cause CNS depression (sedating effects). Since some natural or herbal supplements may also have sedating properties, caution is generally advised regarding concurrent use.


Q: What are the official restrictions for people with a history of seizures using Flexpro extra?

Official regulatory documents advise that the methocarbamol component should be used with caution in patients with a history of epilepsy or convulsive disorders (seizures). Use in these cases requires heightened caution, as noted in official documents.


Q: Can taking Flexpro extra cause blurred or double vision?

Yes, official drug labels list changes to vision, including blurred vision and diplopia (double vision), as reported adverse reactions associated with the use of the drug.


Q: Why might a person taking Flexpro extra be advised to sit up or stand up slowly?

This medication can commonly cause side effects such as dizziness and lightheadedness due to its effects on the central nervous system. These symptoms are typically associated with changes in body position.


Q: Is it possible for the effects of Flexpro extra to be altered in patients with chronic malnutrition?

Official pharmacokinetic data indicates that the body's ability to metabolize and clear the drug may be altered in patients with impaired liver or kidney function. Since chronic health issues can sometimes affect these functions, special consideration may be required in such cases.


Q: What is the primary way Flexpro extra is eliminated from the body?

The methocarbamol component is rapidly metabolized (broken down) in the liver through processes like hydroxylation and conjugation. The substance is then primarily eliminated from the body via renal excretion, meaning it passes out through the urine.


Q: Does official information mention any effect of Flexpro extra on mental status or memory?

Yes, official drug labels for the methocarbamol component list adverse effects related to the central nervous system. These reported effects include confusion, amnesia (memory loss), and mental impairment.


Q: Is Flexpro extra known to cause constipation?

Official documentation for the methocarbamol component lists several gastrointestinal effects, including constipation, as a reported side effect. This is listed alongside other effects like nausea and vomiting.


Q: What are the reasons someone might be advised to avoid combining Flexpro extra with cannabis or marijuana?

Official drug labels state that concurrent use with other substances that cause CNS depression (sedating effects) may result in an increased risk of sedation and drowsiness.


Q: Does Flexpro extra have any known impact on blood pressure?

Yes, official labels list effects on the circulatory system, including hypotension (low blood pressure) and a decrease in heart rate (bradycardia), as reported adverse reactions associated with the methocarbamol component.

Advertisements

How should Flexpro extra (Acetaminophen,Methocarbamol) be stored and disposed of?

Storage and Disposal Requirements

Flexpro extra (Acetaminophen, Methocarbamol) must be stored according to official regulatory standards to maintain product integrity and safety.

Official Storage Conditions

The medicine requires storage at Controlled Room Temperature, which is between 20 C and 25 C (68 F and 77 F), with protection from moisture and excessive heat. It must be dispensed in a tight container and should not be stored in a location like a bathroom, where heat and moisture fluctuate. Crucially, the product must be kept out of the reach of children at all times.

Official Disposal Instructions

If a drug take-back program is unavailable, unused or expired medication should be disposed of in the household trash. This is done by mixing the medicine with an unappealing substance, such as dirt or used coffee grounds, placing the mixture in a sealed bag or container, and discarding it. The product is not on the official flush list and should not be poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flexpro extra (Acetaminophen,Methocarbamol) found in:

A-Z Index: